HIT Consultant January 26, 2024
What You Should Know:
– Deliberate AI, a digital health company harnessing AI to revolutionize mental health assessment, has secured a major milestone in its mission. The U.S. Food and Drug Administration (FDA) has selected Deliberate AI’s AI-generated Clinical Outcome Assessment (AI-COA™) for its Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.
– The collaboration between Deliberate AI and the FDA represents a giant leap in the fight against mental illness. By harnessing the power of AI, we can accelerate drug development, improve treatment efficacy, and ultimately empower patients to live healthier, happier lives
AI-COA™: A Beacon of Precision in Mental Health
Deliberate AI’s AI-COA™ leverages cutting-edge multimodal signal processing and machine learning to capture mental health...
Today's Sponsors
Today's Sponsor
